Mohamed Ayman El‐Zahabi

Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR^WTand EGFR^T790M

Ahmed Abdel Nasser, Ibrahim H. Eissa, Mohamed R. Oun et al. · Organic & Biomolecular Chemistry · 2020 · 118 citations

Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents

Mohamed Ayman El‐Zahabi, Helmy Sakr, Khaled El‐Adl et al. · Bioorganic Chemistry · 2020 · 102 citations

Medicinal Chemistry, Medicine, Immunology +9

Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation

Abdallah E. Abdallah, Sally I. Eissa, Maged Mohammed Saleh Al Ward et al. · Bioorganic Chemistry · 2021 · 67 citations

Medicinal Chemistry, Medicine, Vegfr-2 Kinase Inhibitors +10

New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies

Eslam B. Elkaeed, Mohammed S. Taghour, Hazem A. Mahdy et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · 62 citations · Full text

Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARγ and SUR agonists

Mohamed Ayman El‐Zahabi, Eman R. El‐Bendary, Faida H. Bamanie et al. · Bioorganic Chemistry · 2019 · 58 citations

Molecular Pharmacology, Pharmaceutical Chemistry, Biochemistry +7